Atlas Trials

A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)

Clinical trial NCT01994837 · COMPLETED

Trial details

NCT number
NCT01994837
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaAMLAcute Myeloid Leukemia
Start date
2013-11-01
Primary completion
2014-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.